Literature DB >> 32217195

Radioactive particles released from different sources in the Semipalatinsk Test Site.

S Lukashenko1, A Kabdyrakova2, O C Lind3, I Gorlachev4, A Kunduzbayeva2, T Kvochkina4, K Janssens5, W De Nolf6, Yu Yakovenko2, B Salbu7.   

Abstract

A total of 456 nuclear tests were performed from 1949 to 1989 at the Semipalatinsk Test Site (STS) in Kazakhstan, as part of the nuclear weapon test program of the USSR. To identify if radionuclides such as 137Cs, 90Sr, 241Am, 239+240Pu were associated with radioactive particles, soil samples were collected at selected contaminated sites (i.e. Experimental field, Excavation sites, Fallout plume sections, Background global fallout area, and Degelen Mountain) within the STS. A series of techniques have been applied to identify the size distributions of radionuclides, the prevalence of radioactive particles in soils, and the degree of leachability of particle associated radionuclides by different agents. In addition, selected particles were characterized non-destructively using digital autoradiography, environmental scanning electron microscopy (ESEM) and synchrotron radiation microscopic X-ray techniques. Radioactive particles were identified at all sites; large vitrified particles were identified at epicenters, and the size of particles decreased along the plume with distance from the epicenters. The radioactive particles identified varied in composition, size and leachability. In general, 137Cs, 241Am, 239+240Pu were strongly associated with solid phases (90-99%) in soils, while 90Sr exhibited much greater variability. The fraction of 90Sr present in exchangeable forms was low close to epicenters, while the extractability increased along the plume as the particle size distribution decreased. The results suggest that at least four different types of radioactive particles are present at STS: 1) Relatively large spherical particles with a shiny glazed, melted surface with internal porous structure, and surface layers enriched in transuranic elements, identified at epicenters of detonations, 2) Vitrified irregular particles probably originating from debris of nuclear device with interactions from soil components, also identified at epicenters of detonations, 3) Particles with visually unchanged structure, containing micro-inclusions of fissile materials associated with soil components, also identified at epicenters; 4) Particles with amorphous structures associated with underground detonations, identified in soil in the vicinity of the entrance of the detonation tunnels at the Degelen Mountain. These were probably formed by secondary mechanisms due to sorption and fixation of radionuclides. Thus, the present work shows that the STS should be considered an important observatory site to link particle characteristics to specific sources and to release conditions as well as to ecosystem transfer of particle associated radionuclides.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Mobility; Nuclear tests; Particle size; Radioactive particle characterization; SR-μ-XRF/XRD

Year:  2020        PMID: 32217195     DOI: 10.1016/j.jenvrad.2020.106160

Source DB:  PubMed          Journal:  J Environ Radioact        ISSN: 0265-931X            Impact factor:   2.674


  2 in total

1.  The transfer of 241Am and 137Cs to the tissues of broilers' organs.

Authors:  Ainur S Mamyrbayeva; Zhanat A Baigazinov; Sergey N Lukashenko; Andrey V Panitskiy; Seil S Karatayev; Anton N Shatrov; Symbat A Baigazy; Assem B Bazarbayeva; M Hegedűs; E Tóth-Bodrogi; T Kovács
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

2.  Background Level of Unstable Chromosome Aberrations in the Kazakhstan Population: A Human Biomonitoring Study.

Authors:  Laura B Kenzhina; Aigul N Mamyrbayeva; Sergey N Lukashenko; Zhanat A Baigazinov; Dina B Biyakhmetova; Andrey V Panitskiy; Elena Polivkina; Fail F Zhamaldinov; Clarice Patrono; Valentina Palma; Antonella Testa
Journal:  Int J Environ Res Public Health       Date:  2022-07-12       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.